227 related articles for article (PubMed ID: 7489800)
1. Chronic mucus hypersecretion in COPD and death from pulmonary infection.
Prescott E; Lange P; Vestbo J
Eur Respir J; 1995 Aug; 8(8):1333-8. PubMed ID: 7489800
[TBL] [Abstract][Full Text] [Related]
2. [Chronic expectoration and risk of death in chronic obstructive lung disease].
Prescott EI; Lange P; Vestbo J
Ugeskr Laeger; 1996 Nov; 158(45):6456-60. PubMed ID: 8992683
[TBL] [Abstract][Full Text] [Related]
3. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.
Lange P; Nyboe J; Appleyard M; Jensen G; Schnohr P
Thorax; 1990 Aug; 45(8):579-85. PubMed ID: 2402719
[TBL] [Abstract][Full Text] [Related]
4. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation.
Peto R; Speizer FE; Cochrane AL; Moore F; Fletcher CM; Tinker CM; Higgins IT; Gray RG; Richards SM; Gilliland J; Norman-Smith B
Am Rev Respir Dis; 1983 Sep; 128(3):491-500. PubMed ID: 6614643
[TBL] [Abstract][Full Text] [Related]
5. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
Vestbo J; Prescott E; Lange P
Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
[TBL] [Abstract][Full Text] [Related]
6. The value of mucus hypersecretion as a predictor of mortality and hospitalization. An 11-year register based follow-up study of a random population sample of 876 men.
Vestbo J; Knudsen KM; Rasmussen FV
Respir Med; 1989 May; 83(3):207-11. PubMed ID: 2595038
[TBL] [Abstract][Full Text] [Related]
7. Relevance of airflow obstruction and mucus hypersecretion to mortality.
Wiles FJ; Hnizdo E
Respir Med; 1991 Jan; 85(1):27-35. PubMed ID: 2014356
[TBL] [Abstract][Full Text] [Related]
8. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.
Maestrelli P; Saetta M; Mapp CE; Fabbri LM
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S76-80. PubMed ID: 11734472
[TBL] [Abstract][Full Text] [Related]
9. Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity.
Pistelli R; Lange P; Miller DL
Eur Respir J Suppl; 2003 May; 40():10s-14s. PubMed ID: 12762568
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis of chronic obstructive pulmonary disease.
Markewitz BA; Owens MW; Payne DK
Am J Med Sci; 1999 Aug; 318(2):74-8. PubMed ID: 10452563
[TBL] [Abstract][Full Text] [Related]
11. Mucus hypersecretion in chronic obstructive pulmonary disease.
Rogers DF
Novartis Found Symp; 2001; 234():65-77; discussion 77-83. PubMed ID: 11199104
[TBL] [Abstract][Full Text] [Related]
12. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
Del Donno M; Olivieri D
Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
[TBL] [Abstract][Full Text] [Related]
13. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.
Rogers DF
Monaldi Arch Chest Dis; 2000 Aug; 55(4):324-32. PubMed ID: 11057087
[TBL] [Abstract][Full Text] [Related]
14. Potential misclassification of causes of death from COPD.
Jensen HH; Godtfredsen NS; Lange P; Vestbo J
Eur Respir J; 2006 Oct; 28(4):781-5. PubMed ID: 16807258
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological studies in mucus hypersecretion.
Vestbo J
Novartis Found Symp; 2002; 248():3-12; discussion 12-9, 277-82. PubMed ID: 12568485
[TBL] [Abstract][Full Text] [Related]
16. Exacerbations of chronic obstructive pulmonary disease and chronic mucus hypersecretion.
Tesfaigzi Y; Meek P; Lareau S
Clin Appl Immunol Rev; 2006; 6(1):21-36. PubMed ID: 32288656
[TBL] [Abstract][Full Text] [Related]
17. [Expectoration--an underestimated symptom?].
Vestbo J; Lange P
Ugeskr Laeger; 1993 Sep; 155(39):3100-3. PubMed ID: 8212397
[TBL] [Abstract][Full Text] [Related]
18. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer.
Lange P; Nyboe J; Appleyard M; Jensen G; Schnohr P
Am Rev Respir Dis; 1990 Mar; 141(3):613-7. PubMed ID: 2310094
[TBL] [Abstract][Full Text] [Related]
19. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
Lai H; Rogers DF
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
[TBL] [Abstract][Full Text] [Related]
20. Association of vitamin D binding protein variants with chronic mucus hypersecretion in Iceland.
Laufs J; Andrason H; Sigvaldason A; Halapi E; Thorsteinsson L; Jónasson K; Söebech E; Gislason T; Gulcher JR; Stefansson K; Hakonarson H
Am J Pharmacogenomics; 2004; 4(1):63-8. PubMed ID: 14987123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
